Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Vehicle Controlled Study To Evaluate The Safety, Tolerability, And Efficacy Of DMT210 Gel In Adult Patients With Moderate To Severe Acne Rosacea

NCT03003104 is registered in ClinicalTrials.gov with Dermata Therapeutics as lead sponsor.

NCT NCT03003104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03003104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Vehicle Controlled Study To Evaluate The Safety, Tolerability, And Efficacy Of DMT210 Gel In Adult Patients With Moderate To Severe Acne Rosacea
Lead sponsor
Dermata Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2017
Completion date
August 30, 2017
Enrollment
107 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acne rosacea